Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE - Gaba, Prakriti; O’Donoghue, Michelle L.; Park, Jeong-Gun; Wiviott, Stephen D.; Atar, Dan; Kuder, Julia F.; Im, KyungAh; Murphy, Sabina A.; De Ferrari, Gaetano M.; Gaciong, Zbigniew A.; Toth, Kalman; Gouni-Berthold, Ioanna; et al. (Circulation (New York, N.Y.), 2023)
Keywords: Anticholesteremic Agents - adverse effects; Atherosclerosis - drug therapy; Cardiovascular Diseases - drug therapy; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Myocardial Infarction - epidemiology; PCSK9 Inhibitors; Proprotein Convertase 9; Stroke - epidemiology; Treatment Outcome; atherosclerosis; cholesterol; lipoproteins, LDL; cardiovascular diseases